CL2009001156A1 - Acetato de un peptido de 12 aminoacidos; metodo de preparacion; composicion farmaceutica y agente que lo contiene, solo o conjuntamente con un principio activo que dana el acido nucleico; util para el tratamiento o profilaxis de trastornos proliferativos celulares. - Google Patents

Acetato de un peptido de 12 aminoacidos; metodo de preparacion; composicion farmaceutica y agente que lo contiene, solo o conjuntamente con un principio activo que dana el acido nucleico; util para el tratamiento o profilaxis de trastornos proliferativos celulares.

Info

Publication number
CL2009001156A1
CL2009001156A1 CL2009001156A CL2009001156A CL2009001156A1 CL 2009001156 A1 CL2009001156 A1 CL 2009001156A1 CL 2009001156 A CL2009001156 A CL 2009001156A CL 2009001156 A CL2009001156 A CL 2009001156A CL 2009001156 A1 CL2009001156 A1 CL 2009001156A1
Authority
CL
Chile
Prior art keywords
prophylaxis
acetate
alone
useful
conjunction
Prior art date
Application number
CL2009001156A
Other languages
English (en)
Inventor
Kawabe Takumi
Ishigaki Machiyo
Sato Takuji
Original Assignee
Canbas Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canbas Co Ltd filed Critical Canbas Co Ltd
Publication of CL2009001156A1 publication Critical patent/CL2009001156A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Acetato de un péptido de 12 aminoácidos; método de preparación; composición farmacéutica y agente que lo contiene, solo o conjuntamente con un principio activo que daña el ácido nucleico; útil para el tratamiento o profilaxis de trastornos proliferativos celulares.
CL2009001156A 2008-05-14 2009-05-13 Acetato de un peptido de 12 aminoacidos; metodo de preparacion; composicion farmaceutica y agente que lo contiene, solo o conjuntamente con un principio activo que dana el acido nucleico; util para el tratamiento o profilaxis de trastornos proliferativos celulares. CL2009001156A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5319008P 2008-05-14 2008-05-14
US11684908P 2008-11-21 2008-11-21

Publications (1)

Publication Number Publication Date
CL2009001156A1 true CL2009001156A1 (es) 2010-08-27

Family

ID=40886711

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009001156A CL2009001156A1 (es) 2008-05-14 2009-05-13 Acetato de un peptido de 12 aminoacidos; metodo de preparacion; composicion farmaceutica y agente que lo contiene, solo o conjuntamente con un principio activo que dana el acido nucleico; util para el tratamiento o profilaxis de trastornos proliferativos celulares.

Country Status (9)

Country Link
US (1) US20100112089A1 (es)
CN (1) CN102149725A (es)
AR (1) AR071774A1 (es)
CL (1) CL2009001156A1 (es)
PE (1) PE20091924A1 (es)
RU (1) RU2010150964A (es)
TW (1) TW201000116A (es)
UY (1) UY31826A (es)
WO (1) WO2009139497A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150079623A1 (en) * 2012-03-18 2015-03-19 Kyushu University, National University Corporation Apparatus, system and method for analyzing disease sample
AU2014300713B2 (en) * 2013-06-24 2019-02-14 Canbas Co., Ltd. Peptides and peptidomimetics in combination uses and treatments for cancer patient subpopulations
GB201401877D0 (en) 2014-02-04 2014-03-19 Univ Tromsoe Peptides
US10149887B2 (en) 2015-10-23 2018-12-11 Canbas Co., Ltd. Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment
TWI805542B (zh) * 2015-10-23 2023-06-21 日商坎巴斯有限公司 用於癌症治療之肽及擬肽與ｔ細胞活化劑及／或查核點抑制劑之組合
CA3005730A1 (en) 2015-11-20 2017-05-26 Senhwa Biosciences, Inc. Combination therapy of tetracyclic quinolone analogs for treating cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1218494B1 (en) * 1999-09-22 2005-04-06 Canbas Co., Ltd. Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
KR100863090B1 (ko) * 2002-01-17 2008-10-13 다케다 파머수티컬 컴패니 리미티드 항증식 활성을 지니고／지니거나 핵산 손상제 또는 처리제를 증강시키는 펩티드 및 펩티드모방체
US7125842B2 (en) * 2003-04-07 2006-10-24 Canbas Co. Ltd. Anti-fungal compounds and methods of use
US7358046B2 (en) * 2003-08-08 2008-04-15 Canbas Co., Ltd. Sensitivity test to predict efficacy of anti-cancer therapies
AU2006201635A1 (en) * 2005-10-20 2007-05-10 Ludwig Institute For Cancer Research Novel inhibitors and methods for their preparation
CA2666184A1 (en) * 2006-10-11 2008-04-17 Medvet Science Pty. Ltd. The use of a dna damaging agent and a ligand for the treatment of cancer

Also Published As

Publication number Publication date
US20100112089A1 (en) 2010-05-06
AR071774A1 (es) 2010-07-14
RU2010150964A (ru) 2012-06-20
TW201000116A (en) 2010-01-01
PE20091924A1 (es) 2010-01-04
UY31826A (es) 2010-01-05
WO2009139497A1 (en) 2009-11-19
CN102149725A (zh) 2011-08-10

Similar Documents

Publication Publication Date Title
CL2012001659A1 (es) Composición acuosa antitranspirante/desodorante que comprende a) un activo antitranspirante b) mezcla que comprende al menos una amida básica y/o una amina básica y un material de contraparte para dicha amida y/o amina y c) al menos el 10% en agua; método para producirla; y método para aplicarla.
BR112013018352A2 (pt) composição de minociclina tópica e método
PE20110302A1 (es) Formulacion farmaceutica de un anticuerpo contra p-selectina
BR112014004460A2 (pt) material polimérico para um recipiente isolado
AR082805A1 (es) PEPTIDO O COMPLEJO PEPTIDICO QUE SE UNE A INTEGRINA a2 Y METODOS Y USOS QUE IMPLICAN A LOS MISMOS
PH12013501865A1 (en) Potent and selective inhibitors of nav1.3 and nav1.7
MX2014004725A (es) Formulaciones de etanercept estabilizadas con aminoacidos.
IN2014KN01713A (es)
IN2014KN01714A (es)
IN2014KN01716A (es)
WO2012145665A3 (en) Method of drug delivery for pth, pthrp and related peptides
WO2012103038A3 (en) Nanoparticle compositions, formulations thereof, and uses therefor
WO2007125501A3 (en) Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness
UY31209A1 (es) Uso de homo y copolimeros para la estabilización de formulaciones de principios activos
MX2014001372A (es) Composicion farmaceutica para el tratamiento y/o prevencion de cancer pancreatico.
EP4403579A3 (en) Formulation for anti-alpha4beta7 antibody
WO2008128775A3 (en) Stabilised pharmaceutical composition containing pregabaline
WO2011146922A3 (en) Materials and methods for treatment of inflammation
MX347600B (es) Uso de una composicion que comprende un peptido antimicrobiano como un conservador de alimentos.
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica
MX2012003565A (es) Agentes de despeje de peptido.
BR112013004455A2 (pt) composições para fornecimento gástrico de agentes ativos
CL2009000803A1 (es) Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada
NZ631131A (en) Reconstituted hdl formulation
BR112019003136A2 (pt) forma de dosagem multiunitária de composição farmacêutica, forma de dosagem unitária de composição farmacêutica, forma de dosagem multiunitária / unitária, kit e método de tratamento de uma condição tratável por administração oral de um agente terapeuticamente ativo